No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Tybost is a drug used to treat HIV and hepatitis C infections. It is a once-daily, single-tablet regimen that combines two antiretroviral drugs, cobicistat and elvitegravir. Tybost is used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and adolescents aged 12 years and older. It is also used in combination with other antiviral drugs to treat chronic hepatitis C virus (HCV) infection in adults.
Tybost is part of a growing market of infectious diseases drugs, which are used to treat a variety of illnesses caused by viruses, bacteria, fungi, and parasites. These drugs are used to treat a range of conditions, from common colds to more serious illnesses such as HIV and hepatitis C.
The market for infectious diseases drugs is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Gilead Sciences, Merck & Co., Johnson & Johnson, Pfizer, and GlaxoSmithKline. Other companies in the market include Bristol-Myers Squibb, AbbVie, and Novartis. Show Less Read more
